Figure 1
Figure 1. Treatment schema of 90Y-ibritumomab tiuxetan, fludarabine (30 mg/m2 per day), and cyclophosphamide (750 mg/m2 per day; 90YFC).

Treatment schema of 90Y-ibritumomab tiuxetan, fludarabine (30 mg/m2 per day), and cyclophosphamide (750 mg/m2 per day; 90YFC).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal